drugset / Trial / NCT00896987

Lamotrigine Cognitive Function Study in Adult Untreated Epilepsies

NCT00896987

Phase 4 Completed 121 enrolled Korean Epilepsy Society GlaxoSmithKline · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effect of anti-epileptic drugs' (AEDs) long-term treatment on cognitive function. This study is an open-label, randomized, multicenter comparative trial of lamotrigine versus carbamazepine. The planned enrollment is 100 patients.

Timeline

Start
2006-05
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbamazepine Small molecule 600 mg
Subject Lamotrigine Small molecule 200 mg

Indications